Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Rogers

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
Role of <sup>18</sup>F-FDG-PET/CT in the staging of metastatic rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study GroupFederico Mercolini, Pietro Zucchetta, Nina Jehanno, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2021
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experienceChristophe Bergeron, Meriel Jenney, Federica De Corti, et al.
Pediatric Blood & Cancer|February 17, 2017
Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studiesTimothy Rogers, Veronique Minard-Colin, Nathalie Cozic, et al.
Cancer|October 17, 2022
Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapyGianni Bisogno, Joerg Fuchs, Roshni Dasgupta, et al.
Pediatric Blood & Cancer|March 29, 2019
Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 studyFlorent Guérin, Timothy Rogers, Véronique Minard-Colin, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 28, 2003
The BEST study--a prospective study to compare business class versus economy class air travel as a cause of thrombosisBarry F Jacobson, Marion Münster, Alberto Smith, et al.
Pediatric Blood & Cancer|April 21, 2023
Outcome of patients with undifferentiated embryonal sarcoma of the liver treated according to European soft tissue sarcoma protocolsFlorent Guérin, Hélène Martelli, Timothy Rogers, et al.
Pediatric Blood & Cancer|April 23, 2022
Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studiesTimothy Rogers, Ilaria Zanetti, Beatrice Coppadoro, et al.
Cancer|May 26, 2018
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Soledad Gallego, Ilaria Zanetti, Daniel Orbach, et al.
Cancer|February 24, 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogramGian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
Role of <sup>18</sup>F-FDG-PET/CT in the staging of metastatic rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study GroupFederico Mercolini, Pietro Zucchetta, Nina Jehanno, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2021
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experienceChristophe Bergeron, Meriel Jenney, Federica De Corti, et al.
Pediatric Blood & Cancer|February 17, 2017
Paratesticular rhabdomyosarcoma in children and adolescents-Outcome and patterns of relapse when utilizing a nonsurgical strategy for lymph node staging: Report from the International Society of Paediatric Oncology (SIOP) Malignant Mesenchymal Tumour 89 and 95 studiesTimothy Rogers, Veronique Minard-Colin, Nathalie Cozic, et al.
Cancer|October 17, 2022
Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapyGianni Bisogno, Joerg Fuchs, Roshni Dasgupta, et al.
Pediatric Blood & Cancer|March 29, 2019
Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 studyFlorent Guérin, Timothy Rogers, Véronique Minard-Colin, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 28, 2003
The BEST study--a prospective study to compare business class versus economy class air travel as a cause of thrombosisBarry F Jacobson, Marion Münster, Alberto Smith, et al.
Pediatric Blood & Cancer|April 21, 2023
Outcome of patients with undifferentiated embryonal sarcoma of the liver treated according to European soft tissue sarcoma protocolsFlorent Guérin, Hélène Martelli, Timothy Rogers, et al.
Pediatric Blood & Cancer|April 23, 2022
Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studiesTimothy Rogers, Ilaria Zanetti, Beatrice Coppadoro, et al.
Cancer|May 26, 2018
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Soledad Gallego, Ilaria Zanetti, Daniel Orbach, et al.
Cancer|February 24, 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogramGian Luca De Salvo, Paola Del Bianco, Veronique Minard-Colin, et al.
Pageof 5